Last visit was: 02 May 2026, 16:42 It is currently 02 May 2026, 16:42
Close
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Close
Request Expert Reply
Confirm Cancel
User avatar
PriyankaPalit7
Joined: 28 May 2018
Last visit: 13 Jan 2020
Posts: 117
Own Kudos:
Given Kudos: 883
Location: India
Schools: ISB '21 (A)
GMAT 1: 640 Q45 V35
GMAT 2: 670 Q45 V37
GMAT 3: 730 Q50 V40
Schools: ISB '21 (A)
GMAT 3: 730 Q50 V40
Posts: 117
Kudos: 591
Kudos
Add Kudos
Bookmarks
Bookmark this Post
avatar
Manku
Joined: 15 Aug 2014
Last visit: 22 Jun 2021
Posts: 15
Own Kudos:
Given Kudos: 83
GMAT 1: 630 Q46 V31
GMAT 1: 630 Q46 V31
Posts: 15
Kudos: 3
Kudos
Add Kudos
Bookmarks
Bookmark this Post
avatar
monideepa28
Joined: 19 Jun 2021
Last visit: 03 Nov 2022
Posts: 1
Given Kudos: 20
Posts: 1
Kudos: 0
Kudos
Add Kudos
Bookmarks
Bookmark this Post
User avatar
rocky620
User avatar
Retired Moderator
Joined: 10 Nov 2018
Last visit: 11 May 2023
Posts: 480
Own Kudos:
Given Kudos: 229
Location: India
Concentration: General Management, Strategy
GMAT 1: 590 Q49 V22
WE:Other (Retail: E-commerce)
GMAT 1: 590 Q49 V22
Posts: 480
Kudos: 627
Kudos
Add Kudos
Bookmarks
Bookmark this Post
chetan2u sir

Q. V04-12:

Based on information in the passage, which of the following can be concluded about the function of the substance thromboxane?

In the official explanation
According to the passage, thromboxane constricts vessels and helps blood platelets clump, while PGI2dilates blood vessels and prevents clots..
The highlighted portion clearly indicates the conditions which (can be inferred) are responsible for circulatory disorders. Then why option A is incorrect?
A. Thromboxane is responsible for several types of circulatory disorder.

I agree that option D can also be inferred, but it is just comparing the effects. If we choose this option, then in the absence of PG12, thrombaxane will be deemed harmful/harmless/useful, depending on the context. Whereas A is providing information about its functioning, despite the presence of PG12.
D. Thromboxane balances the effects of PGI2.

Kindly Help.
User avatar
priyanshu14
Joined: 25 Jan 2017
Last visit: 20 Dec 2024
Posts: 72
Own Kudos:
Given Kudos: 71
Location: India
Schools: IIMC MBAEx'23
Schools: IIMC MBAEx'23
Posts: 72
Kudos: 13
Kudos
Add Kudos
Bookmarks
Bookmark this Post
Bunuel
Although the class of anti-inflammatory drugs known as COX-2 inhibitors has proven successful at reducing pain and swelling, a series of clinical trials has shown that these drugs come with potentially harmful side effects. Anti-inflammatory drugs act on prostaglandins, hormone-like substances with a general regulatory role in the body – controlling blood flow to the kidneys or prompting contraction of the uterus during childbirth, for example – in addition to bearing the primary responsibility for causing pain and inflammation. Prostaglandins are the result of a process by which a type of acid in the cell membrane is transformed by two enzymes both known as cyclooxygenase, or COX-1 and COX-2. Older anti-inflammatory medications such as aspirin and ibuprofen stop pain by blocking the action of both COX enzymes. Researchers have long been aware, however, that the simultaneous repression of both COX-1 and COX-2 halts production of all prostaglandins, including those not responsible for pain.

Researchers who developed COX-2 inhibitors hoped to avoid negative side effects by blocking only one of the two COX enzymes. After a series of trials, drugs such as Vioxx and Celebrex entered the market in the 1990s. This approach, unfortunately, soon presented its own drawbacks. Although COX-2 inhibitors do in fact prevent production of prostaglandin E2 (PGE2), which is responsible for causing pain and inflammation, they also inhibit production of various other substances in the body, including prostacyclin (PGI2), which dilates blood vessels and prevents clots. On the other hand, COX-2 inhibitors do not prevent the production of thromboxane, another prostaglandin that constricts vessels and helps blood platelets clump. There is widespread agreement that the next step for researchers is to develop anti-inflammatory drugs that target specific prostaglandins rather than the enzymes that produce them.
1. Which of the following best describes the organization of the passage?

(a) Two options for anti-inflammatory drugs are compared.
(b) The history of a type of medication is outlined.
(c) The function of and problems with a type of medication are presented.
(d) The usefulness of a popular prescription is debated.
(e) New information is used to undermine old assumptions.

2.
According to the passage, a problem with COX-2 inhibitors arises for which of the following reasons?

COX-2 inhibitors


(a) often conflict with older types of anti-inflammatory medication.
(b) cause the production of an excessive amount of prostaglandin E2.
(c) do not suppress an excessive amount of thromboxane, which causes blood clots.
(d) do not account for the complexity of prostaglandin function.
(e) block the production of necessary regulatory substances.

3. Based on information in the passage, which of the following can be concluded about the function of the substance thromboxane?

(a) Thromboxane is responsible for several types of circulatory disorder.
(b) Prostaglandins are made in different cells than thromboxane.
(c) Aspirin does not affect the production of thromboxane.
(d) Thromboxane balances the effects of PGI2.
(e) Thromboxane plays an undetermined role in regulating inflammation.

4. It can be concluded from the passage that COX-2 inhibitors are in danger of accidentally disrupting which of the following bodily processes?

(a) constriction of blood vessels
(b) inflammation
(c) cell division
(d) kidney function
(e) enzyme production


1. Which of the following best describes the organization of the passage?

(a) Two options for anti-inflammatory drugs are compared.
(b) The history of a type of medication is outlined.
(c) The function of and problems with a type of medication are presented.
(d) The usefulness of a popular prescription is debated.
(e) New information is used to undermine old assumptions

Dear bb generis Bunuel GMATNinja egmat VeritasKarishma @payaltondon RaviSreerama, I feel option B and Option C are correct and unable to find reason why Option C is better than option B?
Please support to clarify

Thanks in advance
Priyanshu
User avatar
KarishmaB
Joined: 16 Oct 2010
Last visit: 29 Apr 2026
Posts: 16,448
Own Kudos:
79,475
 [1]
Given Kudos: 485
Location: Pune, India
Products:
Expert
Expert reply
Active GMAT Club Expert! Tag them with @ followed by their username for a faster response.
Posts: 16,448
Kudos: 79,475
 [1]
1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
priyanshu14
Bunuel
Although the class of anti-inflammatory drugs known as COX-2 inhibitors has proven successful at reducing pain and swelling, a series of clinical trials has shown that these drugs come with potentially harmful side effects. Anti-inflammatory drugs act on prostaglandins, hormone-like substances with a general regulatory role in the body – controlling blood flow to the kidneys or prompting contraction of the uterus during childbirth, for example – in addition to bearing the primary responsibility for causing pain and inflammation. Prostaglandins are the result of a process by which a type of acid in the cell membrane is transformed by two enzymes both known as cyclooxygenase, or COX-1 and COX-2. Older anti-inflammatory medications such as aspirin and ibuprofen stop pain by blocking the action of both COX enzymes. Researchers have long been aware, however, that the simultaneous repression of both COX-1 and COX-2 halts production of all prostaglandins, including those not responsible for pain.

Researchers who developed COX-2 inhibitors hoped to avoid negative side effects by blocking only one of the two COX enzymes. After a series of trials, drugs such as Vioxx and Celebrex entered the market in the 1990s. This approach, unfortunately, soon presented its own drawbacks. Although COX-2 inhibitors do in fact prevent production of prostaglandin E2 (PGE2), which is responsible for causing pain and inflammation, they also inhibit production of various other substances in the body, including prostacyclin (PGI2), which dilates blood vessels and prevents clots. On the other hand, COX-2 inhibitors do not prevent the production of thromboxane, another prostaglandin that constricts vessels and helps blood platelets clump. There is widespread agreement that the next step for researchers is to develop anti-inflammatory drugs that target specific prostaglandins rather than the enzymes that produce them.
1. Which of the following best describes the organization of the passage?

(a) Two options for anti-inflammatory drugs are compared.
(b) The history of a type of medication is outlined.
(c) The function of and problems with a type of medication are presented.
(d) The usefulness of a popular prescription is debated.
(e) New information is used to undermine old assumptions.

2.
According to the passage, a problem with COX-2 inhibitors arises for which of the following reasons?

COX-2 inhibitors


(a) often conflict with older types of anti-inflammatory medication.
(b) cause the production of an excessive amount of prostaglandin E2.
(c) do not suppress an excessive amount of thromboxane, which causes blood clots.
(d) do not account for the complexity of prostaglandin function.
(e) block the production of necessary regulatory substances.

3. Based on information in the passage, which of the following can be concluded about the function of the substance thromboxane?

(a) Thromboxane is responsible for several types of circulatory disorder.
(b) Prostaglandins are made in different cells than thromboxane.
(c) Aspirin does not affect the production of thromboxane.
(d) Thromboxane balances the effects of PGI2.
(e) Thromboxane plays an undetermined role in regulating inflammation.

4. It can be concluded from the passage that COX-2 inhibitors are in danger of accidentally disrupting which of the following bodily processes?

(a) constriction of blood vessels
(b) inflammation
(c) cell division
(d) kidney function
(e) enzyme production


1. Which of the following best describes the organization of the passage?

(a) Two options for anti-inflammatory drugs are compared.
(b) The history of a type of medication is outlined.
(c) The function of and problems with a type of medication are presented.
(d) The usefulness of a popular prescription is debated.
(e) New information is used to undermine old assumptions

Dear bb generis Bunuel GMATNinja egmat VeritasKarishma @payaltondon RaviSreerama, I feel option B and Option C are correct and unable to find reason why Option C is better than option B?
Please support to clarify

Thanks in advance
Priyanshu

"A history of something" would typically involve progress on a timeline. In the 1800s, this is how it was. Then in early 1900s, this happened. Then in recent years... etc
This passage is all about how anti-inflammatory drugs work and the side effects they bring along. The mention of a date is not sufficient to make it a history of the development. It ends with the expected next steps that will take care of the side effects.
Option (C) is a much better fit.
User avatar
hdsinghdang
Joined: 04 Apr 2022
Last visit: 20 May 2024
Posts: 11
Own Kudos:
Given Kudos: 414
Location: India
GMAT 1: 760 Q51 V41
GPA: 8.52
GMAT 1: 760 Q51 V41
Posts: 11
Kudos: 2
Kudos
Add Kudos
Bookmarks
Bookmark this Post
I think this is a poor-quality question and I don't agree with the explanation. V04-13

As writtten in the passage:

they (COX-2 Inhibitors) also inhibit production of various other substances in the body, including prostacyclin (PGI2), which dilates blood vessels and prevents clots. On the other hand, COX-2 inhibitors do not prevent the production of thromboxane, another prostaglandin that constricts vessels and helps blood platelets clump.

Question:
It can be concluded from the passage that COX-2 inhibitors are in danger of accidentally disrupting which of the following bodily processes?

Answer should be A: constriction of blood vessels
User avatar
KarishmaB
Joined: 16 Oct 2010
Last visit: 29 Apr 2026
Posts: 16,448
Own Kudos:
Given Kudos: 485
Location: Pune, India
Products:
Expert
Expert reply
Active GMAT Club Expert! Tag them with @ followed by their username for a faster response.
Posts: 16,448
Kudos: 79,475
Kudos
Add Kudos
Bookmarks
Bookmark this Post
hdsinghdang
I think this is a poor-quality question and I don't agree with the explanation. V04-13

As writtten in the passage:

they (COX-2 Inhibitors) also inhibit production of various other substances in the body, including prostacyclin (PGI2), which dilates blood vessels and prevents clots. On the other hand, COX-2 inhibitors do not prevent the production of thromboxane, another prostaglandin that constricts vessels and helps blood platelets clump.

Question:
It can be concluded from the passage that COX-2 inhibitors are in danger of accidentally disrupting which of the following bodily processes?

Answer should be A: constriction of blood vessels

They inhibit production of PG12 which dilates blood vessels and does not prevent production of thromboxane, which constricts vessels.
So they do not disrupt "constriction" of blood vessels (because they do not disrupt thromboxane.)
They actually disrupt dilation of blood vessels because they do disrupt production of PG12.
Sly, eh?!
User avatar
Manvi01
Joined: 09 Jul 2024
Last visit: 09 Feb 2026
Posts: 16
Own Kudos:
Given Kudos: 388
Location: India
Posts: 16
Kudos: 1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
I like the solution - it’s helpful.
User avatar
IshikaS
Joined: 16 Jun 2021
Last visit: 02 May 2026
Posts: 4
Own Kudos:
Given Kudos: 11
Products:
Posts: 4
Kudos: 1
Kudos
Add Kudos
Bookmarks
Bookmark this Post
C is incorrect. "do not suppress an excessive amount of thromboxane, which causes blood clots." - we cannot infer this from the information given in the passage. "do not suppress an excessive amount of thromboxane" can be inferred from "On the other hand, COX-2 inhibitors do not prevent the production of thromboxane" however, we cannot infer from the information given that an excessive amount of thromboxane causes blood clots. (It is possible that the amount of thromboxane over a certain threshold is flushed out of the body or redirected to other parts of the body where its effect is neutralised - there are n number of possible explanations).
E can be verified from "they also inhibit production of various other substances in the body, including prostacyclin (PGI2), which dilates blood vessels and prevents clots." therefore, correct.
User avatar
Vivek1707
Joined: 22 May 2020
Last visit: 02 May 2026
Posts: 115
Own Kudos:
Given Kudos: 133
Products:
Posts: 115
Kudos: 15
Kudos
Add Kudos
Bookmarks
Bookmark this Post
This is a great question that’s helpful for learning.
   1   2 
Moderators:
Math Expert
110017 posts
Founder
43190 posts